Idiopathic thrombocytopenia and neutropenia in childhood. 1994

S Calderwood, and V Blanchette, and J Doyle, and J Freedman, and D Stroncek, and A Zipursky
Department of Paediatrics, Hospital for Sick Children, Toronto, Ontario, Canada.

OBJECTIVE Between 1975 and 1990, 13 patients seen at The Hospital for Sick Children, Toronto, Ontario, were noted to have concurrent idiopathic thrombocytopenia and neutropenia (ITN; platelet count < 150 x 10(9)/L; absolute neutrophil count < 1.5 x 10(9)/L). These patients all had normal marrow function and no evidence of systemic disease. METHODS A detailed chart review was performed to define the clinical and laboratory features of these patients. RESULTS Although this was a heterogeneous group of patients, they shared several common characteristics. The disease followed a chronic course with thrombocytopenia or neutropenia or both that persisted or recurred over the entire period of follow-up in all patients (18 months to 15 years). The disease was associated with splenomegaly in eight patients and lymphadenopathy in nine patients. Boys were affected more frequently than were girls (ratio 11:2). Thrombocytopenia improved temporarily during treatment with corticosteroids, i.v. immunoglobulin G, RhoGAM, and a variety of immunosuppressive agents; however, neutropenia tended to be much more resistant to these therapies. Splenectomy was ineffective in two children in whom the procedure was performed. Platelet of and neutrophil antibodies or both were detected in five of six patients who were tested, suggesting an autoimmune cause for the cytopenias. CONCLUSIONS These findings suggest that ITN in childhood is distinct from immune thrombocytopenic purpura, particularly in terms of its chronicity and poor response to therapy.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D009503 Neutropenia A decrease in the number of NEUTROPHILS found in the blood. Neutropenias
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D013921 Thrombocytopenia A subnormal level of BLOOD PLATELETS. Thrombopenia,Thrombocytopenias,Thrombopenias
D016553 Purpura, Thrombocytopenic, Idiopathic Thrombocytopenia occurring in the absence of toxic exposure or a disease associated with decreased platelets. It is mediated by immune mechanisms, in most cases IMMUNOGLOBULIN G autoantibodies which attach to platelets and subsequently undergo destruction by macrophages. The disease is seen in acute (affecting children) and chronic (adult) forms. Autoimmune Thrombocytopenic Purpura,Idiopathic Thrombocytopenic Purpura,Purpura, Thrombocytopenic, Autoimmune,Werlhof's Disease,Autoimmune Thrombocytopenia,Immune Thrombocytopenia,Immune Thrombocytopenic Purpura,Thrombocytopenic Purpura, Autoimmune,Werlhof Disease,Autoimmune Thrombocytopenias,Autoimmune Thrombocytopenic Purpuras,Disease, Werlhof,Disease, Werlhof's,Idiopathic Thrombocytopenic Purpuras,Immune Thrombocytopenias,Immune Thrombocytopenic Purpuras,Purpura, Autoimmune Thrombocytopenic,Purpura, Idiopathic Thrombocytopenic,Purpura, Immune Thrombocytopenic,Purpuras, Autoimmune Thrombocytopenic,Purpuras, Idiopathic Thrombocytopenic,Purpuras, Immune Thrombocytopenic,Thrombocytopenia, Autoimmune,Thrombocytopenia, Immune,Thrombocytopenias, Autoimmune,Thrombocytopenias, Immune,Thrombocytopenic Purpura, Idiopathic,Thrombocytopenic Purpura, Immune,Thrombocytopenic Purpuras, Idiopathic,Thrombocytopenic Purpuras, Immune,Werlhofs Disease

Related Publications

S Calderwood, and V Blanchette, and J Doyle, and J Freedman, and D Stroncek, and A Zipursky
August 2002, European journal of haematology,
S Calderwood, and V Blanchette, and J Doyle, and J Freedman, and D Stroncek, and A Zipursky
January 1989, European journal of haematology,
S Calderwood, and V Blanchette, and J Doyle, and J Freedman, and D Stroncek, and A Zipursky
January 2002, Pediatric hematology and oncology,
S Calderwood, and V Blanchette, and J Doyle, and J Freedman, and D Stroncek, and A Zipursky
January 1989, The American journal of pediatric hematology/oncology,
S Calderwood, and V Blanchette, and J Doyle, and J Freedman, and D Stroncek, and A Zipursky
January 1998, Ryoikibetsu shokogun shirizu,
S Calderwood, and V Blanchette, and J Doyle, and J Freedman, and D Stroncek, and A Zipursky
January 2003, Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners,
S Calderwood, and V Blanchette, and J Doyle, and J Freedman, and D Stroncek, and A Zipursky
January 1986, American journal of diseases of children (1960),
S Calderwood, and V Blanchette, and J Doyle, and J Freedman, and D Stroncek, and A Zipursky
July 1986, Scottish medical journal,
S Calderwood, and V Blanchette, and J Doyle, and J Freedman, and D Stroncek, and A Zipursky
July 1994, Acta paediatrica (Oslo, Norway : 1992),
S Calderwood, and V Blanchette, and J Doyle, and J Freedman, and D Stroncek, and A Zipursky
January 1986, The American journal of pediatric hematology/oncology,
Copied contents to your clipboard!